STEELE GLENN JR MD PHD
SEC Form 4 insider trading activity
STEELE GLENN JR MD PHD has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.
On the most recent filing, STEELE GLENN JR MD PHD is listed as Director at PTC THERAPEUTICS, INC. Inside the rolling window, STEELE GLENN JR MD PHD reported no open-market purchases and 2 open-market sales totaling $1.7M in PTCT. The largest disclosed transaction in the window is a sale of 12,000 PTCT shares on Jan 2, 2026, worth $916K.
Companies traded
Other insiders at PTCT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has STEELE GLENN JR MD PHD made?
STEELE GLENN JR MD PHD has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does STEELE GLENN JR MD PHD trade?
STEELE GLENN JR MD PHD has filed SEC Form 4 disclosures for 1 company, including PTCT.
When was STEELE GLENN JR MD PHD's most recent SEC Form 4 filing?
STEELE GLENN JR MD PHD's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.
What is STEELE GLENN JR MD PHD's total buy and sell value in the current window?
Inside the rolling retention window, STEELE GLENN JR MD PHD bought $0 and sold $1.7M based on SEC Form 4 filings.
What was STEELE GLENN JR MD PHD's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,000 PTCT shares on 2026-01-02, worth $916K, per SEC Form 4 filings.